Your browser doesn't support javascript.
loading
Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders.
Kennedy, Peter G E; Graner, Michael W; Fringuello, Anthony; Zhou, Wenbo; Pointon, Tiffany; Alquatli, Kinda; Bisel, Sara; Langford, Dianne; Yu, Xiaoli.
Afiliação
  • Kennedy PGE; Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, UK.
  • Graner MW; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Fringuello A; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Zhou W; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Pointon T; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Alquatli K; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Bisel S; Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Langford D; Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Yu X; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. xiaoli.yu@cuanschutz.edu.
J Neuroimmune Pharmacol ; 17(3-4): 526-537, 2022 12.
Article em En | MEDLINE | ID: mdl-34989971

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article